PKCα Isoform Inhibits Insulin Signaling and Aggravates Neuronal Insulin Resistance

Devanshi Mishra1, Ishitha Reddy1, Chinmoy Sankar Dey2

  • 1Kusuma School of Biological Sciences, Indian Institute of Technology-Delhi, New Delhi, Hauz Khas, -110016, India.

PubMed

Insights

Protein kinase C alpha (PKCα) overexpression disrupts insulin signaling in neurons. Inhibiting PKCα enhances insulin sensitivity and glucose uptake, offering new therapeutic targets for metabolic and neurodegenerative disorders.

Area of Science:

  • Neuroscience
  • Metabolic Disorders
  • Cellular Signaling

Background:

  • Protein kinase C alpha (PKCα) role in insulin signaling is controversial and tissue-specific.
  • Previous studies linked PKCα overexpression to inhibited insulin signaling in skeletal muscle, but its precise role remains unclear.
  • The function of PKCα in neuronal insulin resistance and diabetes requires further investigation.

Purpose of the Study:

  • To elucidate the role of PKCα in neuronal insulin signaling and insulin resistance.
  • To investigate the molecular mechanisms by which PKCα affects insulin sensitivity in neuronal cells.
  • To explore the potential of targeting PKCα for treating metabolic and neurodegenerative disorders.

Main Methods:

  • Utilized neuronal cell lines (Neuro-2a, SHSY-5Y) and insulin-resistant diabetic mouse brain tissues.
  • Investigated the interaction of PKCα with insulin signaling pathway components, including IRS-Akt, PP2A, AS160, 14-3-3ζ, and GSK3 isoforms.
  • Assessed the effects of PKCα inhibition and silencing on GLUT-4 translocation, glucose uptake, and insulin sensitivity.

Main Results:

  • PKCα was demonstrated to inhibit insulin signaling in neuronal cells via an IRS-Akt pathway, involving PP2A and 14-3-3ζ, independently of AS160.
  • Inhibition or silencing of PKCα improved insulin sensitivity, increased GLUT-4 translocation to the plasma membrane, and enhanced glucose uptake.
  • PKCα differentially regulated GSK3 isoforms, with higher activity exacerbating insulin resistance in a GSK3β-dependent manner.

Conclusions:

  • PKCα plays a significant role in regulating insulin signaling and contributing to neuronal insulin resistance and diabetes.
  • Targeting PKCα presents a promising therapeutic strategy for metabolic disorders and neurodegenerative conditions.
  • The findings provide mechanistic insights into PKCα's contribution to neuronal dysfunction in diabetes.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.3K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.4K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.7K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.3K